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Purpose of the study
Abnormalities of lipid metabolism are common in HIV-
infected patients and are accentuated in those receiving
antiretroviral therapy, particularly with ritonavir. The
measurement of non-fasting triglyceride levels is not cur-
rently common place as no standard values have been
developed. The purpose of this study is to identify
whether routine non-fasting bloods obtained in clinic are
representative of lipid levels when compared to fasting
levels.
Methods
Patients identified as having triglyceride levels above 3.0
mmol//I were requested to return for fasted sampling
prior to consideration for potential intervention.
Summary of results
• 34 patients with elevated triglyceride levels were
included
• All were males with a mean age of 47(± 8.6) years
See Table 1.
76% of patients had a reduction in their triglyceride levels
with repeated fasting. 81% of patients had a reduction in
their HDL:Cholesterol ratio when bloods were repeated
fasting. Both these results were statistically significant at a
confidence interval of 95%.
Conclusion
All individuals should routinely have their bloods taken
in the fasting state. Failure to do so may result in the inap-
propriate initiation of lipid-lowering agents or potential
treatment changes.
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Table 1: Results of lipid levels when fasted.
Biochemical marker n of group Mean routine lipid levels (mmol/l) Mean percentage reduction with fasted bloods 95% CI
Cholesterol 34 6.04(± 1.2) -4.6% -10.27%, 1.00%
HDL:Cholesterol ratio 11 7.11(± 1.92) -35.4% -56.27%, -14.57%
Triglyceride level 34 5.29(± 2.9) -29.5% -41.33%, -17.64%
